AU2016904629A0 - Formulations for the treatment of mucosal inflammatory disorders - Google Patents

Formulations for the treatment of mucosal inflammatory disorders

Info

Publication number
AU2016904629A0
AU2016904629A0 AU2016904629A AU2016904629A AU2016904629A0 AU 2016904629 A0 AU2016904629 A0 AU 2016904629A0 AU 2016904629 A AU2016904629 A AU 2016904629A AU 2016904629 A AU2016904629 A AU 2016904629A AU 2016904629 A0 AU2016904629 A0 AU 2016904629A0
Authority
AU
Australia
Prior art keywords
formulations
treatment
inflammatory disorders
mucosal inflammatory
mucosal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2016904629A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Newcastle University of Upon Tyne
Original Assignee
Newcastle University of Upon Tyne
Filing date
Publication date
Application filed by Newcastle University of Upon Tyne filed Critical Newcastle University of Upon Tyne
Publication of AU2016904629A0 publication Critical patent/AU2016904629A0/en
Abandoned legal-status Critical Current

Links

AU2016904629A 2016-11-14 Formulations for the treatment of mucosal inflammatory disorders Abandoned AU2016904629A0 (en)

Publications (1)

Publication Number Publication Date
AU2016904629A0 true AU2016904629A0 (en) 2016-11-24

Family

ID=

Similar Documents

Publication Publication Date Title
EP3448874A4 (en) Compositions for the treatment of disease
EP3448875A4 (en) Compositions for the treatment of disease
EP3448987A4 (en) Compositions for the treatment of disease
EP3570844A4 (en) Azolopyrimidine for the treatment of cancer-related disorders
EP3694500A4 (en) Treatment of inflammatory disorders
EP3340982A4 (en) Compounds for treatment of immune and inflammatory disorders
EP3445352A4 (en) Compositions for the treatment of hyperkeratosis disorders
GB201402070D0 (en) Pharmaceutical compositions for the treatment of inflammatory disorders
GB201411241D0 (en) Novel dihydropyridoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders
EP3352749A4 (en) Compounds and compositions for the treatment of ocular disorders
EP3174525A4 (en) Otic formulations for the treatment of ceruminosis
EP3256438A4 (en) Compounds, compositions, and methods for the treatment of inflammatory, degenerative, and neurodegenerative diseases
GB201401086D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
TWI799397B (en) Compositions for the treatment of hypertension
EP3344256A4 (en) Compositions for the treatment of joints
SG11201708181RA (en) Methods for the treatment of inflammatory disorders
EP3288578B8 (en) Compositions for colon cleansing and the treatment of gastrointestinal disorders
EP3256124A4 (en) Cenicriviroc for the treatment of fibrosis
EP3119387A4 (en) Compositions for the treatment of dermatological diseases and disorders
EP3490970A4 (en) Compositions for the treatment of pulmonary fibrosis
EP3439627C0 (en) Composition for use for inflammatory conditions of the mucosa
EP3215178A4 (en) Treatment of cns inflammatory disorders
EP3634395A4 (en) Formulations of lixivaptan for the treatment of polycystic disease
EP3507277B8 (en) Hydroxynorketamine derivatives for the treatment of disorders
EP3463427A4 (en) Methods and compositions for the treatment of secretory disorders